FR2698095B1 - Use of dibenzylethylene diamino diacetate compounds against oxidative stress, pharmaceutical or cosmetic compositions containing them, new compounds and their preparation process. - Google Patents

Use of dibenzylethylene diamino diacetate compounds against oxidative stress, pharmaceutical or cosmetic compositions containing them, new compounds and their preparation process.

Info

Publication number
FR2698095B1
FR2698095B1 FR9213707A FR9213707A FR2698095B1 FR 2698095 B1 FR2698095 B1 FR 2698095B1 FR 9213707 A FR9213707 A FR 9213707A FR 9213707 A FR9213707 A FR 9213707A FR 2698095 B1 FR2698095 B1 FR 2698095B1
Authority
FR
France
Prior art keywords
dibenzylethylene
diamino
pharmaceutical
preparation process
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9213707A
Other languages
French (fr)
Other versions
FR2698095A1 (en
Inventor
Jean-Baptiste Galey
Jacqueline Dumats
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9213707A priority Critical patent/FR2698095B1/en
Application filed by LOreal SA filed Critical LOreal SA
Priority to ES94900187T priority patent/ES2136723T3/en
Priority to PCT/FR1993/001109 priority patent/WO1994011338A1/en
Priority to US08/436,203 priority patent/US5703095A/en
Priority to DE69326776T priority patent/DE69326776T2/en
Priority to AT94900187T priority patent/ATE185548T1/en
Priority to JP51179294A priority patent/JP3510627B2/en
Priority to CA002149431A priority patent/CA2149431A1/en
Priority to EP94900187A priority patent/EP0668854B1/en
Publication of FR2698095A1 publication Critical patent/FR2698095A1/en
Application granted granted Critical
Publication of FR2698095B1 publication Critical patent/FR2698095B1/en
Priority to US08/469,751 priority patent/US5629436A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9213707A 1992-11-13 1992-11-13 Use of dibenzylethylene diamino diacetate compounds against oxidative stress, pharmaceutical or cosmetic compositions containing them, new compounds and their preparation process. Expired - Lifetime FR2698095B1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR9213707A FR2698095B1 (en) 1992-11-13 1992-11-13 Use of dibenzylethylene diamino diacetate compounds against oxidative stress, pharmaceutical or cosmetic compositions containing them, new compounds and their preparation process.
EP94900187A EP0668854B1 (en) 1992-11-13 1993-11-10 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
US08/436,203 US5703095A (en) 1992-11-13 1993-11-10 Use of N-arylmethylene, ethylenediaminetriacetates, N-arymethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress
DE69326776T DE69326776T2 (en) 1992-11-13 1993-11-10 USE OF N-ARYLMETHYLEN ETHYLENDIAMINTRIACETATE, N-ARYLMETHYLEN IMINODIACETAT OR N, N'-DIARYLMETHYLEN ETHYLENDIAMINDIACETAT AGAINST OXIDATIVE STRESS
AT94900187T ATE185548T1 (en) 1992-11-13 1993-11-10 USE OF N-ARYLMETHYLENE ETHYLENEDIAMINE DIACETATE, N-ARYLMETHYLENE IMINODIACETATE OR N,N'-DIARYLMETHYLENE ETHYLENEDIAMINE DIACETATE AGAINST OXIDATIVE STRESS
JP51179294A JP3510627B2 (en) 1992-11-13 1993-11-10 Use of N-arylmethyleneethylenediaminetriacetate, N-arylmethyleneiminodiacetate or N, N'-diarylmethyleneethylenediamine acetate for oxidative stress
ES94900187T ES2136723T3 (en) 1992-11-13 1993-11-10 USE OF N-ARYL-METHYLENE-ETHYL-DIAMINE-TRIACETATES, N-ARYL-METHYLENE-IMINO-DIACETATES OR N, N'-DIARYL-METHYLENE-DIAMINE-ACETATES AGAINST OXIDIZING STRESS.
PCT/FR1993/001109 WO1994011338A1 (en) 1992-11-13 1993-11-10 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacentates or n, n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
CA002149431A CA2149431A1 (en) 1992-11-13 1993-11-10 Use of n-arylmethylene ethylenediamine-triacetates, n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates against oxidizing stress
US08/469,751 US5629436A (en) 1992-11-13 1995-06-06 Use of N-arylmethylene ethylenediaminetriacetates N-arylmethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9213707A FR2698095B1 (en) 1992-11-13 1992-11-13 Use of dibenzylethylene diamino diacetate compounds against oxidative stress, pharmaceutical or cosmetic compositions containing them, new compounds and their preparation process.

Publications (2)

Publication Number Publication Date
FR2698095A1 FR2698095A1 (en) 1994-05-20
FR2698095B1 true FR2698095B1 (en) 1994-12-30

Family

ID=9435539

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9213707A Expired - Lifetime FR2698095B1 (en) 1992-11-13 1992-11-13 Use of dibenzylethylene diamino diacetate compounds against oxidative stress, pharmaceutical or cosmetic compositions containing them, new compounds and their preparation process.

Country Status (1)

Country Link
FR (1) FR2698095B1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724317B1 (en) * 1994-09-08 1996-10-18 Oreal PHOTOCLIVABLE METAL CHELATORS AND COMPOSITIONS CONTAINING THEM
FR2940615B1 (en) 2008-12-30 2011-12-30 Oreal ASSOCIATION OF MONOSACCHARIDES WITH ANTIOXIDANT AGENTS AND ITS USE IN COSMETICS
JP7118591B2 (en) 2017-02-28 2022-08-16 ロレアル Compositions containing resorcinol or derivatives thereof
JP7412898B2 (en) 2019-04-26 2024-01-15 ロレアル Combination of unique particles and lipophilic antioxidants
JP2021095354A (en) 2019-12-16 2021-06-24 ロレアル Stable composition containing combination of specific components
FR3131845A1 (en) 2022-01-19 2023-07-21 L'oreal STABLE COMPOSITION COMPRISING RETINOID
WO2023120259A1 (en) 2021-12-20 2023-06-29 Oreal Stable composition comprising retinoid
WO2023120390A1 (en) 2021-12-20 2023-06-29 L'oreal Stable composition comprising retinoid and ascorbic acid compound
FR3131837B1 (en) 2022-01-19 2024-10-04 Oreal STABLE COMPOSITION COMPRISING A RETINOID AND AN ASCORBIC ACID COMPOUND
WO2024135424A1 (en) 2022-12-20 2024-06-27 L'oreal Composition comprising hyaluronic acid-based polyion complex and hydrophilic or lipophilic antioxidant
FR3145279A1 (en) 2023-01-30 2024-08-02 L'oreal COMPOSITION COMPRISING A POLYIONIC COMPLEX BASED ON HYALURONIC ACID AND A LIPOPHILIC ANTIOXIDANT
FR3145278A1 (en) 2023-01-30 2024-08-02 L'oreal STABLE DISPERSION COMPOSITION COMPRISING A RETINOID
WO2024135577A1 (en) 2022-12-23 2024-06-27 L'oreal Stable dispersion composition comprising retinoid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528196A (en) * 1981-02-23 1985-07-09 The United States Of America As Represented By The Department Of Health And Human Services Chelating agents for the treatment of iron overload

Also Published As

Publication number Publication date
FR2698095A1 (en) 1994-05-20

Similar Documents

Publication Publication Date Title
DZ2128A1 (en) New compounds, process for their preparation and pharmaceutical compositions containing them.
DZ1889A1 (en) New quinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
CY2537B1 (en) Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
FR2718136B1 (en) Amino aromatic compounds, process for their preparation and pharmaceutical compositions containing them.
DZ2300A1 (en) Substituted 6,5-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2299A1 (en) Substituted 6,6-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2197A1 (en) 6-Phenylpyridyl-2-amine derivatives, process for their preparation and pharmaceutical compositions containing them.
FR2567885B1 (en) 3-AMINOPROPOXYARYL DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2694290B1 (en) New phenylimidazolidines which may be substituted, their preparation process, their use as medicaments and the pharmaceutical compositions containing them.
DZ2890A1 (en) 4-Carboxamino-2-substituted-1,2,3,4-tetrahydroquinoline, process for their preparation and pharmaceutical compositions containing them.
DZ1957A1 (en) New piperidine derivatives, process for their preparation and pharmaceutical compositions containing them.
FR2698095B1 (en) Use of dibenzylethylene diamino diacetate compounds against oxidative stress, pharmaceutical or cosmetic compositions containing them, new compounds and their preparation process.
DZ2414A1 (en) 2-amino-6- (2-substituted-4-phenoxy) substituted-pyridines process for their preparation and pharmaceutical compositions containing them.
FR2582309B1 (en) NOVEL MORPHINANE AND MORPHINE DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2716195B1 (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and pharmaceutical compositions containing them
DZ2498A1 (en) New quinoline derivatives process for their preparation and pharmaceutical compositions containing them.
DZ2155A1 (en) Aazetidines, process for their preparation, and pharmaceutical compositions containing them.
FR2705095B1 (en) New substituted indoles, process for their preparation and pharmaceutical compositions containing them.
FR2717802B1 (en) New aromatic compounds, process for their preparation and pharmaceutical compositions containing them.
FR2720397B1 (en) New oxathiolanes, process for their preparation and pharmaceutical compositions containing them.
OA07585A (en) New heterocyclic compounds, their preparation process and pharmaceutical composition containing them.
OA07063A (en) New derivatives of amineothoxy-4 isopropy-2-methyl-2-phenol, their preparation methods and their use as medicaments.
FR2718441B1 (en) New compounds of benzisoséléna-zoline and -zine structure, their preparation process and their therapeutic applications.
DZ2309A1 (en) Pyrrolidinyl- and pyrrolinyl-ethylamine derivatives process for their preparation and pharmaceutical compositions containing them.
DZ2250A1 (en) New compounds, process for their preparation and pharmaceutical compositions containing them.